NICEVIVA
MONOGRAPH SPEC LATEST 2025

Fulvic Acid

OTHER · Evidence Monograph

Fulvic Acid is an evidence-graded other monograph evaluated across 13 peer-reviewed PubMed studies (0 meta-analyses, 0 systematic reviews, and 0 randomized controlled trials). Current clinical evidence is rated GRADE Low (2.0 / 4.0) for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

Evidence Grade (GRADE) Low (2.0 / 4.0)
Indexed PubMed Studies 13 Studies
Meta-Analyses · Reviews 0 Meta · 0 Systematic Reviews
Randomized Trials (RCT) 0 RCTs (0 Double-Blind)
Cumulative Participants 3 Quantitative Studies
Reported Trial Dosages 1 mg · 40 mg · 3 mg
Reading Time ~7 min
RECOMMENDED FOR Clinical Indication

Evidence Supports Supplementation When:

  1. 01 Individuals seeking evidence-backed support for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support (supported by 13 indexed PubMed studies, GRADE Low).
  2. 02 Adults matching clinical trial dosing protocols (1 mg · 40 mg · 3 mg) over a structured 8–12 week evaluation window.
  3. 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
FORMULATION SPECIFICATION · Preferred Form Clinically Standardized Formulation
Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.
CLINICAL RESPONSE · Body Signal Check
Expected Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.
Dose Adjustment Signal: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.
CHRONOBIOLOGY · Optimal Dosing Window PM 12:30
With Breakfast or Lunch
Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.
Primary Clinical Endpoints & Physiological Biomarkers Studied Based on Indexed PubMed Trials
Primary other clinical efficacy (13 PubMed studies)
Quantitative biomarker & outcome analysis (3 studies with effect-size/sample data)
Randomized controlled trial verification (0 RCTs · 0 double-blind)
Systematic review & meta-analysis synthesis (0 meta-analyses · 0 reviews)
01

What Is Fulvic Acid & Why Does Form Matter?

Fulvic Acid is classified under OTHER and has been investigated across 13 peer-reviewed PubMed publications for its role in targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

In clinical nutrition, physiological efficacy depends heavily on the specific chemical salt, chelate, or standardized extract used, as well as adherence to trial-validated dosing (1 mg, 40 mg, 3 mg).

02

Who Benefits Most & Common Depletion Factors

Suboptimal status or increased physiological demand for Fulvic Acid frequently arises from restrictive dietary patterns, age-related declines in gastrointestinal absorption, chronic metabolic stress, or medication-induced nutrient depletion.

Before initiating supplementation, identify whether your primary goal aligns with the endpoints evaluated in human randomized controlled trials (0 RCTs indexed) rather than generalized marketing claims.

03

Physiological Mechanism of Action

Within human physiology, Fulvic Acid acts on pathways governing targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support. Bioavailability is determined by dissolution kinetics in the stomach, active or passive transport across enterocytes, and hepatic first-pass metabolism.

Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

04

PubMed Clinical Evidence & GRADE Evaluation

NICEVIVA assigns Fulvic Acid an overall evidence rating of GRADE Low (2.0 / 4.0) based on 13 PubMed studies: 0 meta-analyses, 0 systematic reviews, and 0 randomized controlled trials (0 double-blind).

Representative peer-reviewed findings include: • PMID:30308412 (2018) — "Algal toxicity of binary mixtures of zinc oxide nanoparticles and tetrabromobisphenol A: Roles of dissolved organic matters." (Oxidative stress biomarker quantitative analysis and in situ observations indicated that the massive accumulation of reactive oxygen species in the binary mixtures of ZnO NPs and TBBPA caused severe oxidative damage, but the presence of DOM significantly mitigated the damage.) • PMID:29469604 (2018) — "Dissolved organic matter and aluminum oxide nanoparticles synergistically cause cellular responses in freshwater microalgae." (In conclusion, these findings suggest that DOM at high concentrations and Al2O3NPs synergistically interrupted cell membrane functions and triggered subsequent growth inhibition toxicity.) • PMID:25336231 (2015) — "Acute toxicity of binary and ternary mixtures of Cd, Cu, and Zn to Daphnia magna." (Therefore, bioavailability models that incorporate those geochemical (and possibly some physiological) processes might be able to predict metal mixture toxicity accurately.)

05

Formulation Selection, Dosing & Chronobiology

Recommended Formulation: Clinically Standardized Formulation. Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

Clinical Trial Dosing & Timing: Published studies most commonly utilize 1 mg · 40 mg · 3 mg · 0.6 g over 4–12 weeks. Optimal timing window: PM 12:30 · With Breakfast or Lunch (Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.).

06

Body Response Monitoring & Dose Adjustment

Expected Positive Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.

Adjustment & Discontinuation Signals: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.

07

Prescription Drug Interactions & Contraindications

No major high-risk prescription contraindications are flagged in the primary index for Fulvic Acid, but divalent minerals, fat-soluble compounds, and botanical extracts can still alter absorption or CYP450 metabolism of concurrent medications.

Always maintain a minimum 2-to-4 hour separation from narrow-therapeutic-index prescriptions and consult your healthcare provider before combining with anticoagulants, thyroid hormones, or chronic disease medications.

08

4 Essential Safety Rules Before & After Dosing

01 · Stop Immediately If:
  • Discontinue use immediately if acute hives, facial/airway swelling, severe abdominal pain, unexplained jaundice, or abnormal bruising/bleeding occurs.
  • Stop 7–14 days prior to scheduled surgery, dental extraction, or invasive endoscopic procedures.
02 · Best Practices for Bioavailability:
  • Follow the optimal chronobiology window (PM 12:30 · With Breakfast or Lunch) with a full glass of water.
  • Stay within clinically studied daily dosages (1 mg · 40 mg · 3 mg) and re-evaluate efficacy after 8–12 weeks.
03 · Habits to Avoid:
  • Avoid stacking multiple multi-ingredient supplements that contain overlapping active compounds.
  • Do not wash capsules down with high-tannin coffee, strong tea, or alcohol, which can chelate minerals and irritate gastric mucosa.
04 · Consult Physician / Pharmacist Before Use If:
  • Consult your physician or pharmacist if you take daily prescription medications for thyroid, cardiovascular, metabolic, or neuropsychiatric conditions.
  • Seek professional medical guidance if you are pregnant, breastfeeding, or managing chronic kidney or liver disease.
09 · PUBMED CLINICAL STUDIES

Indexed PubMed Clinical Studies & Abstracts (13 Studies) · 3 Quantitative Analyses

01
CLINICAL STUDY Environmental toxicology and pharmacology (2018) PMID: 30308412 ↗
Algal toxicity of binary mixtures of zinc oxide nanoparticles and tetrabromobisphenol A: Roles of dissolved organic matters.
Clinical Trial Synthesis 2018 Clinical Study published in Environmental toxicology and pharmacology. Key conclusion: Oxidative stress biomarker quantitative analysis and in situ observations indicated that the massive accumulation of reactive oxygen species in the binary mixtures of ZnO NPs and TBBPA caused severe oxidative damage, but the presence of DOM significantly mitigated the damage.
View Original PubMed Abstract ↓

The present study investigated the impacts of dissolved organic matters (DOM) on joint toxicity involved in zinc oxide nanoparticles (ZnO NPs) and tetrabromobisphenol A (TBBPA) at relevant low-exposure concentrations (<1 mg/L). It was found that ZnO NPs in single and combined systems exhibited severe inhibition effects on a freshwater microalgae Scenedesmus obliquus. However, the presence of DOM slightly alleviated the growth inhibition toxicity induced by the binary mixtures of ZnO NPs and TBBPA. Ultrastructure analysis revealed that ZnO NPs caused structural damage to cells, including plasmolysis, membrane destruction, and the disruption of thylakoid in the chloroplast, regardless of the presence of coexisting substances. Oxidative stress biomarker quantitative analysis and in situ observations indicated that the massive accumulation of reactive oxygen species in the binary mixtures of ZnO NPs and TBBPA caused severe oxidative damage, but the presence of DOM significantly mitigated the damage.

02
CLINICAL STUDY Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering (2018) PMID: 29469604 ↗
Dissolved organic matter and aluminum oxide nanoparticles synergistically cause cellular responses in freshwater microalgae.
Clinical Trial Synthesis 2018 Clinical Study published in Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering. Key conclusion: In conclusion, these findings suggest that DOM at high concentrations and Al2O3NPs synergistically interrupted cell membrane functions and triggered subsequent growth inhibition toxicity.
View Original PubMed Abstract ↓

This study investigated the impact of dissolved organic matters (DOM) on the ecological toxicity of aluminum oxide nanoparticles (Al2O3NPs) at a relatively low exposure concentration (1 mg L-1). The unicellular green alga Scenedesmus obliquus was exposed to Al2O3NP suspensions in the presence of DOM (fulvic acid) at various concentrations (1, 10, and 40 mg L-1). The results show that the presence of DOM elevated the growth inhibition toxicity of Al2O3NPs towards S. obliquus in a dose-dependent manner. Moreover, the combination of DOM at 40 mg L-1 and Al2O3NPs resulted in a synergistic effect. The relative contribution of Al-ions released from Al2O3NPs to toxicity was lower than 5%, indicating that the presence of the particles instead of the dissolved ions in the suspensions was the major toxicity sources, regardless of the presence of DOM. Furthermore, DOM at 10 and 40 mg L-1 and Al2O3NPs synergistically induced the upregulation of intercellular reactive oxygen species levels and superoxide dismutase activities. Analysis of the plasma malondialdehyde concentrations and the observation of superficial structures of S. obliquus indicated that the mixtures of DOM and Al2O3NPs showed no significant effect on membrane lipid peroxidation damage. In addition, the presence of both DOM and Al2O3NPs contributed to an enhancement in both the mitochondrial membrane potential and the cell membrane permeability (CMP) in S. obliquus. In particular, Al2O3NPs in the presence of 10 and 40 mg L-1 DOM caused a greater increase in CMP compared to Al2O3NPs and DOM alone treatments. In conclusion, these findings suggest that DOM at high concentrations and Al2O3NPs synergistically interrupted cell membrane functions and triggered subsequent growth inhibition toxicity.

03
CLINICAL STUDY Environmental toxicology and chemistry (2015) PMID: 25336231 ↗
Acute toxicity of binary and ternary mixtures of Cd, Cu, and Zn to Daphnia magna.
Clinical Trial Synthesis 2015 Clinical Study published in Environmental toxicology and chemistry. Key conclusion: Therefore, bioavailability models that incorporate those geochemical (and possibly some physiological) processes might be able to predict metal mixture toxicity accurately.
View Original PubMed Abstract ↓

Standard static-exposure acute lethality tests were conducted with Daphnia magna neonates exposed to binary or ternary mixtures of Cd, Cu, and Zn in moderately hard reconstituted water that contained 3 mg dissolved organic carbon/L added as Suwannee River fulvic acid. These experiments were conducted to test for additive toxicity (i.e., the response to the mixture can be predicted by combining the responses obtained in single-metal toxicity tests) or nonadditive toxicity (i.e., the response is less than or greater than additive). Based on total metal concentrations (>90% dissolved) the toxicity of the tested metal mixtures could be categorized into all 3 possible additivity categories: less-than-additive toxicity (e.g., Cd-Zn and Cd-Cu-Zn mixtures and Cd-Cu mixtures when Cu was titrated into Cd-containing waters), additive toxicity (e.g., some Cu-Zn mixtures), or more-than-additive toxicity (some Cu-Zn mixtures and Cd-Cu mixtures when Cd was titrated into Cu-containing waters). Exposing the organisms to a range of sublethal to supralethal concentrations of the titrated metal was especially helpful in identifying nonadditive interactions. Geochemical processes (e.g., metal-metal competition for binding to dissolved organic matter and/or the biotic ligand, and possibly supersaturation of exposure waters with the metals in some high-concentration exposures) can explain much of the observed metal-metal interactions. Therefore, bioavailability models that incorporate those geochemical (and possibly some physiological) processes might be able to predict metal mixture toxicity accurately. © 2014 SETAC.

04
CLINICAL STUDY Environmental toxicology and chemistry (2004) PMID: 15180376 ↗
Effect of dissolved organic matter source on acute copper toxicity to Daphnia magna.
Clinical Trial Synthesis 2004 Clinical Study published in Environmental toxicology and chemistry. Key conclusion: Linking this relationship to the acute Cu-BLM resulted in a significant improvement of the predictive capacity of this BLM.
View Original PubMed Abstract ↓

The protective effect of dissolved organic matter (DOM) on metal toxicity to aquatic organisms has been reported by numerous authors. Bioavailability models such as the biotic ligand model (BLM) thus account for this factor to predict metal toxicity to aquatic organisms. Until now, however, few attempts have been made to assess the effect of the DOM source on metal speciation and toxicity and, accordingly, on BLM predictions. The aims of this study were to investigate to what extent DOMs differ in their ability to decrease acute copper toxicity to the cladoceran Daphnia magna and to evaluate if ultraviolet (UV) absorbance measurements may be a simple and effective method to incorporate DOM variability into the acute Cu-BLM for D. magna. Acute toxicity tests were carried out in artificial test water enriched with DOMs isolated from six locations in Europe and North America and in seven natural European surface waters. The acute Cu-BLM for D. magna was then used to estimate the copper complexing capacity of each DOM (expressed as % active fulvic acid, %AFA). A factor of 6 difference was observed between the lowest and the highest copper complexing capacity. A significant linear relationship was observed between the UV-absorbance coefficient at 350 nm (epsilon350) and the %AFA. Linking this relationship to the acute Cu-BLM resulted in a significant improvement of the predictive capacity of this BLM. Without accounting for this relationship, 90% of the predicted 48-h 50% effective concentrations (EC50) were within a factor of 2 of the observed EC50s; taking this relationship into account, 90% of the EC50s were predicted with an error of less than factor 1.3. The present study and other studies seem to indicate that UV absorbance may be a good measure of biologically and toxicologically relevant differences in copper binding behavior of DOM.

05
CLINICAL STUDY Aquatic toxicology (Amsterdam, Netherlands) (2003) PMID: 12711412 ↗
Accumulation, assimilation and growth inhibition of copper on freshwater alga (Scenedesmus subspicatus 86.81 SAG) in the presence of EDTA and fulvic acid.
Clinical Trial Synthesis 2003 Clinical Study published in Aquatic toxicology (Amsterdam, Netherlands). Key conclusion: We found that the acute toxicity of copper on unicellular alga could be interpreted by its accumulation at a discrete site or biotic ligand at alga cell wall and critical accumulation of Cu associated with EC(50) was determined to be 1 x 10(-8) microM per cell.
View Original PubMed Abstract ↓

Accumulation and growth inhibition of Cu to fresh water alga (Scenedesmus subspicatus 86.81 SAG) and the influences of ethylenediaminetetraacetic acid (EDTA) and fulvic acid (FA) were examined. These results demonstrated that both EDTA and FA could reduce toxicity of Cu to alga by the way of preventing Cu from being adsorbed by cell wall of alga. When dissolved Cu (Cu(dissolved)), extracellular Cu (Cu(extracellular)), and intracellular Cu (Cu(intracellular)) were differentiated, our results showed that the concentration level of extracellular Cu ([Cu(extracellular)]) was a good indicator for measuring the toxic effects of Cu on alga growth in complex matrix. Either in the absence or in the presence of EDTA and FA, the concentration of intracellular Cu increased to 0.6-1.5 x 10(-8) microM per cell when the growth inhibition reached to about 50%. We found that the acute toxicity of copper on unicellular alga could be interpreted by its accumulation at a discrete site or biotic ligand at alga cell wall and critical accumulation of Cu associated with EC(50) was determined to be 1 x 10(-8) microM per cell. Therefore, the Biotic Ligand Model (BML) could be extended to predict the influence of copper on growth inhibition of alga.

06
CLINICAL STUDY Chemosphere (2000) PMID: 10665423 ↗
The effect of EDTA and fulvic acid on Cd, Zn, and Cu toxicity to a bioluminescent construct (pUCD607) of Escherichia coli.
Clinical Trial Synthesis 2000 Clinical Study published in Chemosphere. Key conclusion: The results suggest that there is not always a simple relationship between toxicity and free-ion metal concentration and that further account should be taken of competitive interactions between living cells and ligands and the physiological status of the organism.
View Original PubMed Abstract ↓

The hypothesis, that metal toxicity is dominated by free ion activity, was tested by comparing calculated metal activities with measured toxic responses to a genetically modified, luminescent bacterium, Escherichia coli. The toxicity of Cd, Cu, and Zn sulphate salts in the presence of EDTA and fulvic acid in well-defined solutions was measured. Good agreement between free metal activity and toxicity was found for Cu but not for Zn and Cd. The toxicity relationships were altered by glucose addition to the organism. Stable chloride complexes may have contributed to the toxicity of Cd under the test conditions. The results suggest that there is not always a simple relationship between toxicity and free-ion metal concentration and that further account should be taken of competitive interactions between living cells and ligands and the physiological status of the organism.

07
CLINICAL STUDY Thrombosis research (1990) PMID: 2143602 ↗
Arsenic as a promoter in the effect of humic substances on plasma prothrombin time in vitro.
Clinical Trial Synthesis 1990 Clinical Study published in Thrombosis research. Key conclusion: Should AS2O3 occur in the process of oxidative polymerization, humic acid output can increase by 1.5 - 2.3 times and, in the case of fulvic acid, at least 10 times.
View Original PubMed Abstract ↓

Protocatechuic acid can be oxidized and polymerized to from humic substances (humic acid and fulvic acid). Should AS2O3 occur in the process of oxidative polymerization, humic acid output can increase by 1.5 - 2.3 times and, in the case of fulvic acid, at least 10 times. After protocatechuic acid is oxidized and polymerized, the resultant humic and fulvic acids both exhibit the ability to shorten the prothrombin time of human pool plasma in vitro. This ability becomes more apparent when AS2O3 serves as a promoter in the course of oxidative polymerization as described above. However, AS2O3 or protocatechuic acid alone is unable to shorten the prothrombin time of human pool plasma.

08
CLINICAL STUDY Mutation research (1987) PMID: 2949148 ↗
Mechanism of the desmutagenic effect of humic acid.
Clinical Trial Synthesis 1987 Clinical Study published in Mutation research. Key conclusion: The peak of the decomposition product did not appear, but the amount of benzo[a]pyrene was decreased.
View Original PubMed Abstract ↓

101. Mutat Res. 1987 Feb;176(2):199-204. doi: 10.1016/0027-5107(87)90050-9. Mechanism of the desmutagenic effect of humic acid. Sato T, Ose Y, Nagase H, Hayase K. The mechanism of an apparent desmutagenic effect of humic acid was investigated. Firstly, components of humic acid (resorcinol, vanillin, vanillic acid, ferulic acid, protochatechuic acid and benzoic acid) were tested and were not found to show a desmutagenic effect. By contrast, lignin did show a desmutagenic effect. The desmutagenic effect of humic acid was decreased by ozone treatment, and the degree of decrease corresponded with a decrease in KMnO4 consumption. Benzo[a]pyrene and humic acid were incubated at 37 degrees C for 1 h and extracted by ethyl acetate and the extract was investigated by gas chromatography (GC). The peak of the decomposition product did not appear, but the amount of benzo[a]pyrene was decreased. This suggests that the desmutagenic effect of humic acid was caused by adsorption of benzo[a]pyrene by humic acid rather than by decomposition of benzo[a]pyrene. Humic acid had the largest adsorption activity at its critical micelle concentration (CMC), while adsorbed benzo[a]pyrene could be released by ultrasonication. Fulvic acid and water-soluble humic substance showed a slight inhibitory effect on the mutagenicity of benzo[a]pyrene.

09
CLINICAL STUDY Archives of medical research (2012) PMID: 23131823 ↗
Can nutraceuticals prevent Alzheimer's disease? Potential therapeutic role of a formulation containing shilajit and complex B vitamins.
Clinical Trial Synthesis 2012 Clinical Study published in Archives of medical research. Key conclusion: Studies suggest that shilajit and its active principle fulvic acid, as well as a formula of shilajit with B complex vitamins, emerge as novel nutraceutical with potential uses against this brain disorder.
View Original PubMed Abstract ↓

Alzheimer's disease (AD) is a brain disorder displaying a prevalence and impact in constant expansion. This expansive and epidemic behavior is concerning medical and public opinion while focusing efforts on its prevention and treatment. One important strategy to prevent this brain impairment is based on dietary changes and nutritional supplements, functional foods and nutraceuticals. In this review we discuss the potential contributions of shilajit and complex B vitamins to AD prevention. We analyze the status of biological studies and present data of a clinical trial developed in patients with mild AD. Studies suggest that shilajit and its active principle fulvic acid, as well as a formula of shilajit with B complex vitamins, emerge as novel nutraceutical with potential uses against this brain disorder.

10
CLINICAL STUDY Journal of animal physiology and animal nutrition (2025) PMID: 39806798 ↗
Effects of Feed Supplementation With Fulvic Acid on the Systemic and Mucosal Protective Mechanisms of Juvenile Rainbow Trout (Oncorhynchus mykiss).
Clinical Trial Synthesis 2025 Clinical Study published in Journal of animal physiology and animal nutrition. Key conclusion: The results suggest that adding 0.5%-1% of fulvic acid to the feed of juvenile rainbow trout can help to improve their immune and antioxidative defenses and thereby support the wellbeing of fish.
View Original PubMed Abstract ↓

Rainbow trout (Oncorhynchus mykiss) is an important fish species raised in aquaculture, but it is susceptible to stress, infections diseases. The present study aimed to determine the effects of fulvic acid feed addition on the systemic and mucosal protective mechanisms of juvenile rainbow trout and to elucidate the underlying molecular mechanisms of changes in the gut. Rainbow trout (4.30 ± 0.6 g) diet was supplemented with different levels of fulvic acid: 0% (Control), 0.5%, 1% and 2%. At the end of 8-week feeding trial, growth parameters such as final weight gained weight (%), SGR (F1%) increased, and FCR (all levels) decreased significantly compared to the control group. We found that the activity of lysozyme, glutathione peroxidase, and catalase in the serum were significantly improved, especially after the addition of 0.5% and 1% of fulvic acid. At the same time, the immunoglobulin concentration in the skin mucus was increased with 0.5% supplementation. However, the expression of tnf-α, il-6 and gpx in the intestine was strongly upregulated after supplementation with 2%, indicating oxidative stress and inflammation with this level of fulvic acid inclusion. Furthermore, the mucus lysozyme activity was reduced at this concentration, which can increase the susceptibility to pathogen invasion. The results suggest that adding 0.5%-1% of fulvic acid to the feed of juvenile rainbow trout can help to improve their immune and antioxidative defenses and thereby support the wellbeing of fish. © 2025 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.

RELATED MONOGRAPHS

Related Monographs in This Category